[Bevacizumab in combination with first-line treatment for metastatic non-small cell lung cancer in clinical practice. Results of the EOLE study].
Fiche publication
Date publication
janvier 2017
Journal
Revue des maladies respiratoires
Auteurs
Membres identifiés du Cancéropôle Est :
Dr SCHOTT Roland
Tous les auteurs :
Chouaid C, Falchero L, Schott R, Bonnetain F, Taguieva-Pioger N, Bennouna J
Lien Pubmed
Résumé
The EOLE cohort aimed to describe, in routine clinical practice, the characteristics and management of patients receiving bevacizumab in combination with first-line metastatic chemotherapy for advanced metastatic or recurrent non squamous non-small cell lung cancer (nsNSCLC), as well as its efficacy and safety.
Référence
Rev Mal Respir. 2017 Jan;34(1):36-43